상세 보기
A phase III, randomized study of adjuvant sacituzumab tirumotecan (sac-TMT) plus pembrolizumab vs treatment of physician's choice (TPC) in patients with TNBC who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery
- Dent, R. A.;
- Hui, R.;
- Park, Y. H.;
- Schmid, P.;
- Wei, J.;
- 외 4명
Citations
WEB OF SCIENCE
1Citations
SCOPUS
0- 제목
- A phase III, randomized study of adjuvant sacituzumab tirumotecan (sac-TMT) plus pembrolizumab vs treatment of physician's choice (TPC) in patients with TNBC who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery
- 저자
- Dent, R. A.; Hui, R.; Park, Y. H.; Schmid, P.; Wei, J.; Mejia, J. A.; Pan, W.; Cortes, J.; McArthur, H. L.
- 발행일
- 2024-12
- 유형
- Meeting Abstract
- 권
- 35
- 페이지
- S1413 ~ S1413